510(k) Report

510(k) · Cleared

Cleared

Atlas Spine HiRISE™ Expandable Cervical Corpectomy System

K252560510(k) TraditionalCleared Nov 10, 202589-day reviewClass II21 CFR 888.3060

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Atlas Spine, Inc. · PLR Spinal Vertebral Body Replacement Device - Cervical

Cleared on Nov 10, 2025 after an 89-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Nov 10, 2025
Review
89 days
Class
Class II
Product code
PLR
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K252560Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PLR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PLR device

  1. #1 K232481 RIGEL™ 3DR Anterior Cervical Corpectomy Systemscore 13.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All PLR devices

PLR Spinal Vertebral Body Replacement Device - Cervical: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · PLR

1in 2025

2015: 12016: 12017: 12018: 32019: 52020: 22022: 22023: 22025: 12026 (partial year): 1
2007high 5 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PLR

69in 2019

2018: 259 days median2019: 69 days median
2007high 259 (2018) · low 69 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PLR

No recall names PLR since 2007.

Adverse event reports per year · PLR

1in 2025

2018: 12019: 12020: 22021: 42022: 12025: 1
2007high 4 (2021) · low 0 (2007)2025

MAUDE reports naming product code PLR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20151—00
20161—00
20171—00
2018325901
201956901
20202—02
20210—04
20222—01
20232—00
20240—00
20251—01
20261—0—

What is it indicated for?

The Atlas Spine HiRISE™ Expandable Cervical Corpectomy System is indicated for vertebral body replacement in the cervical spine (C2-T1). The System is designed for use with autogenous and/or allogeneic bone graft comprised of cancellous and/or corticocancellous bone graft as an adjunct to fusion. When used in the cervical spine (C2-T1), Atlas Spine HiRISE™ Expandable Cervical Corpectomy System spacers are intended for use in skeletally mature patients to…

Read the full statement (178 words)

The Atlas Spine HiRISE™ Expandable Cervical Corpectomy System is indicated for vertebral body replacement in the cervical spine (C2-T1). The System is designed for use with autogenous and/or allogeneic bone graft comprised of cancellous and/or corticocancellous bone graft as an adjunct to fusion.

When used in the cervical spine (C2-T1), Atlas Spine HiRISE™ Expandable Cervical Corpectomy System spacers are intended for use in skeletally mature patients to replace a diseased or damaged vertebral body caused by tumor, fracture, or osteomyelitis, or for reconstruction following corpectomy performed to achieve decompression of the spinal cord and neural tissues in the cervical degenerative disorders. These spacers are intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the cervical spine in whom life expectancy is of insufficient duration to permit achievement of fusion, with bone graft used at the surgeon's discretion. The System is intended to be used with supplemental fixation that has been cleared by the FDA for use in the cervical spine.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K252560: Atlas Spine HiRISE™ Expandable Cervical Corpectomy System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K252560

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026